(PRWEB) December 05, 2012
Gallus BioPharmaceuticals, LLC (Gallus) announced that Mr. Joseph (Joe) Coffey has joined the company as Chief Commercial Officer to lead the sales and marketing organizations.
Joe joins Gallus at a time of accelerating growth following completion of a $ 20 million expansion which added development, clinical and commercial manufacturing contract services for bulk biopharmaceuticals.
I am very excited to join the Gallus team and help it realize its vision. Gallus has the experienced staff, superior regulatory history, and cutting-edge technologies to deliver high quality, cost-effective biologics to the pharma and biotech industry. Gallus combines the requisite infrastructure of big pharma with its unique entrepreneurial focus on delighting clients said Joe Coffey, Chief Commercial Officer of Gallus BioPharmaceuticals.
Joe brings a wealth of proven commercial experience in Sales, Marketing, Sales Force Effectiveness, and Key Account Management. Prior to joining Gallus, Joe was the Vice President, Sales for the BioPharma Solutions franchise within Baxter International Inc., providing contract manufacturing services to pharmaceutical and biotech clients. In this role, Joe led the global strategic accounts management team and developed relationships that helped establish Baxter as a globally recognized leader in contract fill/finish.
Prior to joining Baxter in 2008, Joe served the Diagnostic, Health Systems, and International business units at Abbott, Inc. for nearly two decades in a variety of progressive commercial leadership roles.
Joe also serves as a member of the Board of Directors for the Strategic Account Management Association. Joe has a Bachelor of Science in Economics from the University of Wisconsin-Madison.
I am delighted to have Joe Coffey joining Gallus as our Chief Commercial Officer. Gallus is building on its 26 year experience of providing high quality process development, clinical and commercial supplies of biopharmaceuticals. The addition of Joe is an important step towards realizing our vision to be the Contract Manufacturer of choice for our industry said Mark R. Bamforth, President and CEO of Gallus BioPharmaceuticals.
About Gallus BioPharmaceuticals
Gallus BioPharmaceuticals is a leading contract manufacturing company offering exceptional contract services to its clients. The firm, based in St. Louis, Mo., was established in 2010 and acquired a world-class commercial biopharmaceutical manufacturing facility and workforce from Johnson & Johnson/Centocor division in 2011. In addition to process development and clinical supply services, Gallus currently produces two commercial products that are distributed globally. The St. Louis facility has been inspected by every major regulatory body worldwide. For additional information on biopharmaceutical contract development and manufacturing services, visit http://www.gallusbiopharma.com, email info(at)gallusbiopharma(dot)com or call directly at (314) 426-5000.